Citation: K. Bjamason et al., LEVORMELOXIFENE, A NEW PARTIAL ESTROGEN-RECEPTOR AGONIST DEMONSTRATESANTIRESORPTIVE AND ANTIATHEROGENIC PROPERTIES IN POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 479-479
Citation: Bk. Skrumsager et al., LEVORMELOXIFENE - ESCALATING SINGLE ORAL DOSES IN HEALTHY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 480-480
Citation: Bk. Skrumsager et al., LEVORMELOXIFENE - SAFETY AND PHARMACOKINETICS AFTER MULTIPLE DOSING OF 56 POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 481-481
Authors:
SKRUMSAGER BK
CHRISTENSEN JV
SNEL S
SEIBERLING M
Citation: Bk. Skrumsager et al., TOLERABILITY, SAFETY AND PHARMACOKINETICS OF SINGLE-DOSE AND MULTIPLEDOSING OF THE SELECTIVE D1 ANTAGONIST NNC-01-0687 IN HEALTHY-SUBJECTS, Psychopharmacology, 121(3), 1995, pp. 294-299
Authors:
KARLE J
CLEMMESEN L
HANSEN L
ANDERSEN M
ANDERSEN J
FENSBO C
SLOTHNIELSEN M
SKRUMSAGER BK
LUBLIN H
GERLACH J
Citation: J. Karle et al., NNC-01-0687, A SELECTIVE DOPAMINE D1 RECEPTOR ANTAGONIST, IN THE TREATMENT OF SCHIZOPHRENIA, Psychopharmacology, 121(3), 1995, pp. 328-329